Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,005,884
-$694,297 QoQ
Shares Held
51,084
-10.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#193
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 20261832 Asset Management L.P. holds $1,536,520,507 across 9 Drug Manufacturers - General names. NVS ranks #6 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,162,034 | $549,091,774 | |
| 2 | LLY |
ELI LILLY & Co
|
396,979 | $476,148,561 | |
| 3 | AZN |
Astrazeneca PLC
|
1,215,636 | $230,508,898 | |
| 4 | ABBV |
AbbVie Inc.
|
775,386 | $195,118,133 | |
| 5 | MRK |
Merck & Co., Inc.
|
520,333 | $66,862,790 | |
| 6 | NVS |
Novartis AG
This page
|
51,084 | $8,005,884 | |
| 7 | PFE |
Pfizer Inc
|
235,637 | $5,674,138 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
52,979 | $3,052,649 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,005,884 | 51,084 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $8,700,181 | 56,957 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $8,181,067 | 59,339 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $923,328 | 7,200 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $786,807 | 6,502 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $707,006 | 6,342 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $597,872 | 6,144 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $731,067 | 6,356 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $655,367 | 6,156 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $637,934 | 6,595 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $969,211 | 9,599 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $663,923 | 6,518 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $672,262 | 6,662 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,026,904 | 11,162 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $973,879 | 10,735 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $904,214 | 11,896 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,036,506 | 12,262 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,155,492 | 13,168 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,135,273 | 12,979 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,035,825 | 12,666 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,221,794 | 13,391 | Shares | Sole | 2021-08-20 | |
| 2021-03-31 | $1,375,629 | 16,093 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,588,029 | 16,817 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,352,228 | 15,550 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,199,876 | 13,738 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,367,989 | 65,106 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||